Copyright
©The Author(s) 2025.
World J Hepatol. Sep 27, 2025; 17(9): 109340
Published online Sep 27, 2025. doi: 10.4254/wjh.v17.i9.109340
Published online Sep 27, 2025. doi: 10.4254/wjh.v17.i9.109340
Table 1 Evolution of hepatitis B pentameter and liver function during the treatment of patients with chronic hepatitis B
Weeks | Treatment regimen | HBV-DNA (IU/mL) | HBsAg (0-0.05 IU/mL) | HBsAb (0-10 mIU/mL) | HBeAg (0-0.18 PEIU/mL) | HBeAb (1-999 S/CO) | HBcAb (0-1 S/CO) | ALT (0-40 U/L) | AST (0-40 U/L) | GGT (0-58 U/L) | CAP (< 238 dB/m) | LSM (2.5-7kPa) | AST/ALT | |
0 | ETV | < 251 | 29.93 | 0.029 | 0.029 | 1.093 | 0.029 | 29 | 37 | 35 | 269 | 6.3 | 1.28 | |
4 | ETV + PEG | — | 445.65 | 0.68 | 0.11 | 1.14 | 8.94 | 71 | 75 | 53 | - | - | 1.06 | |
8 | ETV + PEG | — | 337.45 | 0.24 | 0.09 | 1.13 | 8.75 | 216 | 217 | 95 | - | - | 1.00 | |
12 | ETV + PEG | 8.0E + 011 | 49.48 | 0.31 | 0.11 | 1.16 | 8.92 | 126 | 129 | 105 | - | - | 1.02 | |
16 | ETV + PEG | 1.40E + 021 | 5.47 | 0.28 | 0.1 | 1.15 | 8.03 | 109 | 116 | 113 | 230 | 7.1 | 1.06 | |
33 | ETV + PEG | 1.73E + 021 | 0.42 | 1.96 | 0.11 | 1.1 | 6.99 | 122 | 119 | 120 | 278 | 7.9 | 0.98 | |
48 | ETV + PEG | 1.77E + 022 | 0.06 | 6 | 0.11 | 1.13 | 9.37 | 61 | 73 | 86 | 294 | 11.7 | 1.19 | |
OBI phase | 61 | ETV + PEG | 3.70E + 012 | 0.01 | 52.18 | 0.14 | 1.2 | 8.55 | 91 | 101 | 119 | - | - | 1.11 |
72 | ETV + PEG | 9.20E + 012 | 0.01 | 142.41 | 0.14 | 1.3 | 9.32 | 98 | 119 | 117 | 253 | 9.8 | 1.21 | |
82 | PEG | 1.90E + 012 | 0 | 134.59 | 0.14 | 1.55 | 8.44 | 122 | 157 | 112 | - | - | 1.29 | |
91 | PEG | 1.10E + 012 | 0.01 | 82.28 | 0.13 | 1.3 | 7.12 | 73 | 90 | 119 | - | - | 1.23 | |
101 | PEG | < 102 | 0.02 | 49.55 | 0.15 | 1.32 | 7.51 | 65 | 80 | 94 | - | - | 1.23 | |
115 | PEG | 4.10E + 012 | 0.02 | 58.37 | 0.18 | 1.54 | 7.53 | 30 | 72 | 120 | - | - | 2.40 | |
120 | D/C PEG for 1 months | < 102 | 0 | 89.18 | 0.22 | 1.43 | 7.64 | - | - | - | - | - | - | |
129 | D/C PEG for 3 months | < 102 | 0 | 91.6 | 0.16 | 1.36 | 6.37 | 26 | 29 | 34 | - | - | 1.12 | |
140 | D/C PEG for 6 months | < 102 | 0 | 112.26 | 0.14 | 1.32 | 8.73 | 23 | 25 | 33 | - | - | 1.09 | |
154 | D/C PEG for 9 months | - | 0 | 123.62 | 0.16 | 1.34 | 7.05 | 18 | 26 | 28 | - | - | 1.44 | |
174 | D/C PEG for 13 months | < 102 | 0 | 44.04 | 0.15 | 1.42 | 6.49 | 20 | 26 | 26 | 176 | 7 | 1.30 | |
188 | D/C PEG for 17 months | < 102 | 0.03 | 30.84 | 0.18 | 1.46 | 6.61 | 20 | 30 | 30 | - | - | 1.60 | |
212 | D/C PEG for 23 months | < 251 | 0 | 8.11 | 0.17 | 1.02 | 6.31 | 20 | 29 | 30 | 239 | 5.9 | 1.45 |
- Citation: Wang L, Liang H, Wang C, Liang MY, Zeng QL, Zhu PF, Lv J. Functional cure in an occult hepatitis B virus infection patient on sequential therapy: A case report. World J Hepatol 2025; 17(9): 109340
- URL: https://www.wjgnet.com/1948-5182/full/v17/i9/109340.htm
- DOI: https://dx.doi.org/10.4254/wjh.v17.i9.109340